L3Harris Technologies
LHX
233.63
-4.27
-1.79%
L3Harris Technologies
US · LHX
#495 by market cap
Listed 1970
233.63
-4.27
-1.79%
Live - 5344 symbols - heartbeat 505s ago
· 2026-10-08 07:40
Pre-market
233.63
0.00%
After-hours
234.75
+0.48%
Overnight
233.25
-0.16%
- Market cap
- 43.51B
- P/E (TTM)i
- 23.60
- P/Bi
- 2.19
- EPSi
- 8.53
- Div yieldi
- 2.10%
- 52W posi
- 0%
Reader sentiment
Are you bullish or bearish on LHX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.10, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.53% YoY
Margins
- Gross margin
- 25.73%
- Operating margin
- 9.83%
- Net margin
- 7.35%
Key ratios & quality
- Enterprise valuei
- 53.55B
- PEG ratioi
- 1.60
- Altman Z-Scorei
- 2.10
PEG uses trailing P/E against the 3-year net income growth rate (14.78%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2020 | 2020 | 2021 | 2022 | 2023 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.17B | 9.26B | 18.19B | 17.81B | 17.06B | 19.42B | 21.33B | 21.87B |
| Gross profit | 2.10B | 2.54B | 5.31B | 5.38B | 4.93B | 5.11B | 5.52B | 5.63B |
| Selling & admin expenses | 1.18B | 1.88B | 3.32B | 3.28B | 3.00B | 3.31B | 2.22B | 2.23B |
| Research & development | -- | -- | -- | -- | -- | -- | 515.00M | 536.00M |
| Operating profit | 920.00M | 656.00M | 1.99B | 2.10B | 1.93B | 1.80B | 2.02B | 2.15B |
| Pretax profit | 908.00M | 908.00M | 1.32B | 2.28B | 1.27B | 1.22B | 1.60B | 1.93B |
| Tax | 206.00M | 73.00M | 234.00M | 440.00M | 212.00M | 23.00M | 85.00M | 326.00M |
| Net profit | 699.00M | 834.00M | 1.09B | 1.84B | 1.06B | 1.20B | 1.51B | 1.61B |
| Basic EPS | 6 | 4 | 5 | 9 | 6 | 6 | 8 | 9 |
| Diluted EPS | 5.76 | 3.67 | 5.19 | 9.09 | 5.49 | 6.44 | 7.87 | 8.53 |
| Line item | 2025-03 | 2025-06 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 5.13B | 5.43B | 5.66B | 5.65B | 5.74B | 5.88B |
| Gross profit | 1.35B | 1.34B | 1.49B | 1.45B | 1.40B | 1.50B |
| Selling & admin expenses | 508.00M | 443.00M | 549.00M | 739.00M | 455.00M | 515.00M |
| Research & development | 111.00M | 131.00M | 137.00M | 155.00M | 146.00M | 160.00M |
| Operating profit | 554.00M | 584.00M | 631.00M | 376.00M | 642.00M | 664.00M |
| Pretax profit | 459.00M | 524.00M | 567.00M | 382.00M | 589.00M | 710.00M |
| Tax | 73.00M | 66.00M | 105.00M | 82.00M | 77.00M | 110.00M |
| Net profit | 386.00M | 458.00M | 462.00M | 300.00M | 512.00M | 600.00M |
| Basic EPS | 2 | 2 | 2 | 2 | 3 | 3 |
| Diluted EPS | 2.04 | 2.44 | 2.46 | 1.59 | 2.72 | 3.13 |
Balance sheet
| Line item | 2018 | 2020 | 2020 | 2021 | 2022 | 2023 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.22B | 6.31B | 6.67B | 6.36B | 6.75B | 8.06B | 8.22B | 8.59B |
| Cash & ST investments | 288.00M | 824.00M | 1.28B | 941.00M | 880.00M | 560.00M | 615.00M | 1.07B |
| Inventory | 411.00M | 1.22B | 973.00M | 982.00M | 1.29B | 1.47B | 1.33B | 1.22B |
| Total assets | 9.85B | 38.34B | 36.96B | 34.71B | 33.52B | 41.69B | 42.00B | 41.20B |
| Total current liabilities | 1.85B | 4.01B | 4.24B | 4.55B | 5.78B | 8.00B | 7.63B | 7.23B |
| Short-term debt | 382.00M | 260.00M | 10.00M | 13.00M | 820.00M | 1.97B | 1.16B | 673.00M |
| Long-term debt | 3.41B | 6.69B | 6.94B | 7.05B | 6.23B | 11.16B | 11.08B | 10.44B |
| Total liabilities | 6,573,000,000.00 | 15,592,000,000.00 | 16,119,000,000.00 | 15,390,000,000.00 | 14,900,000,000.00 | 22,858,000,000.00 | 22,422,000,000.00 | 21,560,000,000.00 |
| Total equity | 3.28B | 22.74B | 20.84B | 19.32B | 18.62B | 18.83B | 19.58B | 19.64B |
| Retained earnings | 1.65B | 2.18B | 2.35B | 2.92B | 2.94B | 3.22B | 3.74B | 4.21B |
| Line item | 2025-03 | 2025-06 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 7.60B | 7.61B | 7.59B | 8.59B | 8.89B | 10.08B |
| Cash & ST investments | 517.00M | 482.00M | 339.00M | 1.07B | 590.00M | 1.52B |
| Inventory | 1.25B | 1.26B | 1.29B | 1.22B | 1.23B | 1.27B |
| Total assets | 41.25B | 41.24B | 41.01B | 41.20B | 41.38B | 42.94B |
| Total current liabilities | 7.45B | 7.32B | 6.64B | 7.23B | 8.60B | 8.52B |
| Short-term debt | 1.28B | 1.13B | 725.00M | 673.00M | 2.17B | 1.82B |
| Long-term debt | 10.98B | 10.98B | 11.00B | 10.44B | 9.19B | 9.18B |
| Total liabilities | 22,118,000,000.00 | 21,962,000,000.00 | 21,482,000,000.00 | 21,560,000,000.00 | 21,700,000,000.00 | 22,088,000,000.00 |
| Total equity | 19.13B | 19.28B | 19.53B | 19.64B | 19.68B | 20.85B |
| Retained earnings | 3.79B | 3.97B | 4.17B | 4.21B | 4.42B | 4.72B |
Cash flow
| Line item | 2018 | 2020 | 2020 | 2021 | 2022 | 2023 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 751.00M | 939.00M | 2.79B | 2.69B | 2.16B | 2.10B | 2.56B | 3.11B |
| Depreciation & amortization | 259.00M | 442.00M | 1.03B | 967.00M | 938.00M | 1.17B | 1.29B | 1.22B |
| Free cash flow | 615.00M | 766.00M | 2.42B | 2.35B | 1.91B | 1.65B | 2.15B | 2.68B |
| Dividends paid | -272.00M | -337.00M | -725.00M | -817.00M | -864.00M | -868.00M | -886.00M | -903.00M |
| Stock buybacks / issuance | -272.00M | -1.50B | -2.29B | -3.68B | -1.08B | -518.00M | -554.00M | -1.15B |
| Ending cash balance | 288.00M | 824.00M | 1.28B | 941.00M | 880.00M | 560.00M | 615.00M | 1.07B |
| Line item | 2025-03 | 2025-06 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | -42.00M | 640.00M | 546.00M | 1.96B | -95.00M | 879.00M |
| Depreciation & amortization | 301.00M | 303.00M | 309.00M | 311.00M | 282.00M | 288.00M |
| Free cash flow | -101.00M | 552.00M | 427.00M | 1.80B | -194.00M | 771.00M |
| Dividends paid | -228.00M | -225.00M | -225.00M | -225.00M | -238.00M | -232.00M |
| Stock buybacks / issuance | -569.00M | -253.00M | -176.00M | -156.00M | -296.00M | 744.00M |
| Ending cash balance | 517.00M | 482.00M | 339.00M | 1.07B | 590.00M | 1.52B |
Returns & efficiency
| Line item | 2018 | 2020 | 2020 | 2021 | 2022 | 2023 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 22.98 | -- | 5.17 | 9.24 | 5.63 | 6.58 | 7.85 | 8.20 |
| ROA %i | 7.21 | -- | 2.97 | 5.15 | 3.11 | 3.26 | 3.59 | 3.86 |
| ROIC %i | 12.07 | -- | 4.53 | 7.43 | 4.85 | 6.05 | 6.73 | 6.73 |
| 5-year avg ROE %i | 19.02 | 18.42 | -- | -- | -- | -- | 6.89 | 7.50 |
| EBIT margin %i | 17.73 | 13.30 | 8.75 | 14.30 | 9.10 | 9.08 | 10.65 | 11.57 |
| FCF / sales %i | 9.95 | 10.80 | 13.31 | 13.16 | 11.17 | 8.48 | 10.09 | 12.27 |
| Current ratioi | 1.20 | 1.79 | 1.57 | 1.40 | 1.17 | 1.01 | 1.08 | 1.19 |
| Quick ratioi | 0.92 | 0.26 | 1.26 | 1.12 | 0.89 | 0.63 | 0.69 | 0.84 |
| Debt / assetsi | 38.47 | 2.11 | 20.80 | 22.56 | 21.01 | 31.48 | 29.13 | 26.98 |
| LT debt / equityi | 103.97 | 3.43 | 37.04 | 40.68 | 33.61 | 59.47 | 56.78 | 53.19 |
| Interest coveragei | 6.45 | 7.88 | 5.90 | 9.62 | 5.56 | 3.25 | 3.37 | 4.24 |
| Revenue CAGR (3Y) %i | 16.66 | 4.31 | 37.89 | 35.32 | 29.99 | 2.20 | 6.18 | 8.62 |
| Net income CAGR (3Y) %i | 27.91 | 43.08 | 22.90 | 31.91 | 3.26 | 3.12 | -6.64 | 14.78 |
| FCF CAGR (3Y) %i | -4.50 | 9.87 | 61.60 | 46.47 | 19.38 | -12.06 | -2.84 | 12.06 |
| Line item | 2025-03 | 2025-06 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 8.49 | 8.90 | 9.13 | 8.20 | 8.93 | 9.50 |
| ROA %i | 3.86 | 4.09 | 4.24 | 3.86 | 4.19 | 4.42 |
| ROIC %i | 6.89 | 7.12 | 7.25 | 6.73 | 7.12 | 7.47 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.37 | 11.83 | 12.20 | 11.57 | 11.77 | 12.24 |
| FCF / sales %i | 10.68 | 10.12 | 8.69 | 12.27 | 11.52 | 12.24 |
| Current ratioi | 1.02 | 1.04 | 1.14 | 1.19 | 1.03 | 1.18 |
| Quick ratioi | 0.79 | 0.80 | 0.88 | 0.84 | 0.70 | 0.84 |
| Debt / assetsi | 29.70 | 29.35 | 28.58 | 26.98 | 27.45 | 25.62 |
| LT debt / equityi | 57.38 | 56.94 | 56.30 | 53.19 | 46.70 | 46.19 |
| Interest coveragei | 3.72 | 4.02 | 4.31 | 4.24 | 4.54 | 5.01 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Space & Mission Systems (SMS) is the largest reported line at 50.43% of revenue, across 4 reported segments.
- Communication & Spectrum Dominance (CSD) follows at 33.04%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Space & Mission Systems (SMS)50.43%
Communication & Spectrum Dominance (CSD)33.04%
Missile Solutions (MSL)17.92%
Quote time 2026-10-08 07:40:17 · For reference only, not investment advice and not tailored to your situation.